Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Huanan Pharmaceutical Group is a China-based pharmaceutical manufacturer focused on the research, production, and commercialization of chemical drug formulations and selected traditional Chinese medicine products. The company appears to operate primarily as a commercial-stage branded generic and formulation manufacturer rather than an innovation-driven clinical biotech. Publicly visible products and filings indicate capabilities across tablets, capsules, granules, suspensions, softgels, sprays, and dropping pills, with marketed or registered products including cefixime granules, carbamazepine tablets, rebamipide tablets, metformin tablets, and pranoprofen eye drops. Huanan Pharma is a wholly owned subsidiary within the Zhongsheng Pharmaceutical group and is headquartered in Dongguan, Guangdong, China. Its recent activity includes bioequivalence studies and formulation patents supporting lifecycle management and generic drug registration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Huanan Pharmaceutical Group.